封面
市場調查報告書
商品編碼
1441469

生命科學軟體市場規模 - 類型、應用、組件、解決方案 - 區域展望、競爭策略、細分市場預測(~2033 年)

Life Science Software Market Size- By Type, By Application, By Component, By Solutions - Regional Outlook, Competitive Strategies and Segment Forecast to 2033

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 234 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

到 2033 年,生命科學軟體市場規模預計將成長至 647.1 億美元,預測期內年複合成長率為 13.11%。

全球生命科學軟體市場受到 COVID-19 爆發的嚴重影響。開發針對這種病毒的治療方法和疫苗的迫切需求正在推動對支持藥物發現、基因組學和臨床試驗的軟體解決方案的需求。由於面對面會議的禁止,需要遠端工作和協作工具,這促使人們採用雲端基礎的平台和線上協作工具。

該報告調查了全球生命科學軟體市場,並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭形勢以及主要企業。總結的。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 促進因素、限制因素、機會與挑戰分析
  • COVID-19 對市場的影響

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭形勢

  • 製造地、銷售區域、產品類型分佈
  • 併購、聯盟、產品發布、合作

第7章全球生命科學軟體市場:依類型

  • 全球市佔率及預測
  • 說明的
  • 預測性的
  • 規定性的

第8章全球生命科學軟體市場:依應用分類

  • 全球市佔率及預測
  • 遵守
  • 行銷
  • R&D
  • 藥物安全檢測
  • SCM

第9章全球生命科學軟體市場:按組成部分

  • 全球市佔率及預測
  • 軟體
  • 服務

第10章全球生命科學軟體市場:按解決方案

  • 全球市佔率及預測
  • 雲端基礎
  • 本地

第11章全球生命科學軟體市場預測

  • 市場規模/市場佔有率趨勢/預測

第12章全球生命科學軟體市場:按類型

  • 市場規模/市場佔有率趨勢/預測

第13章全球生命科學軟體市場:依應用分類

  • 市場規模/市場佔有率趨勢/預測

第 14 章全球生命科學軟體市場:按組成部分

  • 市場規模/市場佔有率趨勢/預測

第15章全球生命科學軟體市場:按解決方案

  • 市場規模/市場佔有率趨勢/預測

第16章全球生命科學軟體市場:按地區

  • 市場規模/市場佔有率趨勢/預測
  • 亞太地區
  • 歐洲
  • 中東/非洲
  • 北美洲
  • 拉丁美洲

第17章 公司簡介

  • Allscripts Healthcare LLC
  • Cerner Corporation
  • Cognizant
  • CPSI
  • Elinext
  • EPIC System Corporation
  • INFOR
  • Jag Products LLC
  • Meta
  • Oracle
  • 其他

第18章簡稱表

第19章 參考鏈接

第20章結論

第21章 研究範圍

簡介目錄
Product Code: IACT2434

Life Science Software Market Introduction and Overview

According to SPER market research, 'Life Science Software Market - By Type, By Application, By Component, By Solution- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Life Science Software Market is predicted to reach USD 64.71 billion by 2033 with a CAGR of 13.11%.

Life science software includes a range of tools for standardizing workflow and document management in the biopharmaceutical, medical technology, generics, and clinical care sectors. These programs allow businesses to capture, store, and preserve data using images and text. There are various types of life science software available, such as drug identification and validation, laboratory management, clinical trial management, and medical device development.

Furthermore, the global market for life science software has been significantly affected by the COVID-19 pandemic. Because of the urgency of developing treatments and vaccines for the virus, there is an increased demand for software solutions that aid in drug discovery, genomics, and clinical trials. The ban on in-person meetings necessitated remote work and collaboration tools, hastening the adoption of cloud-based platforms and online collaboration tools.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Type, By Application, By Component, By Solution

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Allscripts Healthcare LLC, Cerner Corporation , Cognizant, CPSI , Elinext , EPIC Systems Corporation, INFOR, Jag products LLC ,Meta, Oracle

Global Life Science Software Market Segmentation:

By Type: Based on the Type, Global Life Science Software Market is segmented as; Descriptive, Predictive and Prescriptive.

By Application: Based on the Application, Global Life Science Software Market is segmented as; Compliance, Marketing, R & D, Pharmacovigilance and SCM.

By Component: Based on the Component, Global Life Science Software Market is segmented as; Software and Services.

By Solutions: Based on the Solutions, Global Life Science Software Market is segmented as; Cloud- Based and On- Premises.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Life Science Software Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Life Science Software Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Life Science Software Market

7. Global Life Science Software Market, By Type (USD Million)

  • 7.1. Global Life Science Software Market Value Share and Forecast, By Type, 2024-2033
  • 7.2. Descriptive
  • 7.3. Predictive
  • 7.4. Prescriptive

8. Global Life Science Software Market, By Application (USD Million)

  • 8.1. Global Life Science Software Market Value Share and Forecast, By Application, 2024-2033
  • 8.2. Compliance
  • 8.3. Marketing
  • 8.4. R &D
  • 8.5. Pharmacovigilance
  • 8.6. SCM

9. Global Life Science Software Market, By Component (USD Million)

  • 9.1. Global Life Science Software Market Value Share and Forecast, By Component, 2024-2033
  • 9.2. Software
  • 9.3. Services

10. Global Life Science Software Market, By Solution (USD Million)

  • 10.1. Global Life Science Software Market Value Share and Forecast, By Solution, 2024-2033
  • 10.2. Cloud- Based
  • 10.3. On- Premises

11. Global Life Science Software Market Forecast, 2020-2033 (USD Million)

  • 11.1. Global Life Science Software Market Size and Market Share

12. Global Life Science Software Market, By Type, 2020-2033 (USD Million)

  • 12.1. Global Life Science Software Market Size and Market Share By Type (2020-2026)
  • 12.2. Global Life Science Software Market Size and Market Share By Type (2027-2033)

13. Global Life Science Software Market, By Application, 2020-2033 (USD Million)

  • 13.1. Global Life Science Software Market Size and Market Share By Application (2020-2026)
  • 13.2. Global Life Science Software Market Size and Market Share By Application (2027-2033)

14. Global Life Science Software Market, By Component, 2020-2033 (USD Million)

  • 14.1. Global Life Science Software Market Size and Market Share By Component (2020-2026)
  • 14.2. Global Life Science Software Market Size and Market Share By Component (2027-2033)

15. Global Life Science Software Market, By Solution, 2020-2033 (USD Million)

  • 15.1. Global Life Science Software Market Size and Market Share By Solution (2020-2026)
  • 15.2. Global Life Science Software Market Size and Market Share By Solution (2027-2033)

16. Global Life Science Software Market, By Region, 2020-2033 (USD Million)

  • 16.1. Global Life Science Software Market Size and Market Share By Region (2020-2026)
  • 16.2. Global Life Science Software Market Size and Market Share By Region (2027-2033)
  • 16.3. Asia-Pacific
    • 16.3.1. Australia
    • 16.3.2. China
    • 16.3.3. India
    • 16.3.4. Japan
    • 16.3.5. South Korea
    • 16.3.6. Rest of Asia-Pacific
  • 16.4. Europe
    • 16.4.1. France
    • 16.4.2. Germany
    • 16.4.3. Italy
    • 16.4.4. Spain
    • 16.4.5. United Kingdom
    • 16.4.6. Rest of Europe
  • 16.5. Middle East and Africa
    • 16.5.1. Kingdom of Saudi Arabia
    • 16.5.2. United Arab Emirates
    • 16.5.3. Rest of Middle East & Africa
  • 16.6. North America
    • 16.6.1. Canada
    • 16.6.2. Mexico
    • 16.6.3. United States
  • 16.7. Latin America
    • 16.7.1. Argentina
    • 16.7.2. Brazil
    • 16.7.3. Rest of Latin America

17. Company Profile

  • 17.1. Allscripts Healthcare LLC
    • 17.1.1. Company details
    • 17.1.2. Financial outlook
    • 17.1.3. Product summary
    • 17.1.4. Recent developments
  • 17.2. Cerner Corporation
    • 17.2.1. Company details
    • 17.2.2. Financial outlook
    • 17.2.3. Product summary
    • 17.2.4. Recent developments
  • 17.3. Cognizant
    • 17.3.1. Company details
    • 17.3.2. Financial outlook
    • 17.3.3. Product summary
    • 17.3.4. Recent developments
  • 17.4. CPSI
    • 17.4.1. Company details
    • 17.4.2. Financial outlook
    • 17.4.3. Product summary
    • 17.4.4. Recent developments
  • 17.5. Elinext
    • 17.5.1. Company details
    • 17.5.2. Financial outlook
    • 17.5.3. Product summary
    • 17.5.4. Recent developments
  • 17.6. EPIC System Corporation
    • 17.6.1. Company details
    • 17.6.2. Financial outlook
    • 17.6.3. Product summary
    • 17.6.4. Recent developments
  • 17.7. INFOR
    • 17.7.1. Company details
    • 17.7.2. Financial outlook
    • 17.7.3. Product summary
    • 17.7.4. Recent developments
  • 17.8. Jag Products LLC
    • 17.8.1. Company details
    • 17.8.2. Financial outlook
    • 17.8.3. Product summary
    • 17.8.4. Recent developments
  • 17.9. Meta
    • 17.9.1. Company details
    • 17.9.2. Financial outlook
    • 17.9.3. Product summary
    • 17.9.4. Recent developments
  • 17.10. Oracle
    • 17.10.1. Company details
    • 17.10.2. Financial outlook
    • 17.10.3. Product summary
    • 17.10.4. Recent developments
  • 17.11. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope